In a recent paper in Nature, Bryan Roth et al. revealed detailed features in the recognition of DREADD actuators by designer receptors. Muscarinic DREADDs or designer receptors exclusively activated by designer drugs, are the most widely used chemogenetic tools in neuroscience research. One of the most commonly employed DREADD actuators is clozapine N-oxide.
